The effect of tumor size and lymph node status on breast carcinoma lethality

被引:101
作者
Michaelson, JS
Silverstein, M
Sgroi, D
Cheongsiatmoy, JA
Taghian, A
Powell, S
Hughes, K
Comegno, A
Tanabe, KK
Smith, B
机构
[1] Massachusetts Gen Hosp, Div Surg Oncol, Dept Pathol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA USA
[5] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
关键词
breast carcinoma; risk of death; tumor size; lymph node status;
D O I
10.1002/cncr.11765
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. It has long been known that both tumor size and the presence of malignant disease in the regional lymph nodes are indicators Of Outcome for patients with invasive breast carcinoma; however, the way in which these two characteristics could be integrated into an overall assessment of prognosis has not been obvious. METHODS. Kaplan-Meier survival estimates (15 years) according to tumor size and lymph node status were obtained for women with invasive breast carcinoma who were observed at the University of Southern California/Van Nuys Breast Center (Van Nuys, California) or at Massachusetts General Hospital (Boston, Massachusetts). RESULTS. To isolate the individual contributions to death made by tumor size and lymph node status, data were sorted according to both of these variables. For women with turners of equivalent size, lethality increased with increasing number of positive lymph nodes, such that there was an extra approximate to6% chance of death associated with each positive lymph node. For women with equivalent lvmph node status, turner size was associated with increased lethality, such that each millimeter of tumor diameter was associated with an additional approximate to1% chance of death. The overall lethality was equal to the sum of the contribution from lvmph node status and the contribution from tumor size, and this finding led to the creation of a new technique (the Size+Nodes method) for predicting outcome. CONCLUSIONS. The Size+Nodes method was shown to be capable of accurately estimating the risk of death due to invasive breast carcinoma from information on the size of the primary tumor and the number of positive lymph nodes. In addition, this method was used to stratify women into groups according to breast carcinoma lethality. In contrast, classification of women according to lymph node positivity, T status, or disease stage created groups with wide and overlapping levels of lethality. (C) 2003 American Cancer Society.
引用
收藏
页码:2133 / 2143
页数:11
相关论文
共 20 条
[1]  
Abner AL, 1998, CANCER-AM CANCER SOC, V83, P2502, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2502::AID-CNCR14>3.3.CO
[2]  
2-9
[3]  
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[4]  
2-H
[5]   Role of immunohistochemical detection of lymph-node metastases in management of breast cancer [J].
Cote, RJ ;
Peterson, HF ;
Chaiwun, B ;
Gelber, RD ;
Goldhirsch, A ;
Castiglione-Gertsch, M ;
Gusterson, B ;
Neville, AM .
LANCET, 1999, 354 (9182) :896-900
[6]   Molecular prognostic markers in breast cancer [J].
Dahiya, R ;
Deng, GR .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :185-200
[7]  
Davis AR, 1996, BRIT J BIOMED SCI, V53, P157
[8]   Oncogene products and other diagnostic markers in human breast cancer patients - Treatment effects and their significance [J].
Dowsett, M ;
Makris, A ;
Ellis, P ;
Johnston, SRD ;
Salter, J ;
Detre, S ;
Humphries, S ;
SaccaniJotti, G ;
Powles, TJ ;
Smith, IE .
BASIS FOR CANCER MANAGEMENT, 1996, 784 :403-411
[9]  
*EUR GROUP TUM MAR, 1999, ANTICANCER RES A, V194, P2803
[10]  
FISHER ER, 1993, CANCER-AM CANCER SOC, V71, P2141, DOI 10.1002/1097-0142(19930315)71:6+<2141::AID-CNCR2820711603>3.0.CO